Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

B3(Fv)-PE38KDEL recombinant immunotoxin × Other hematologic neoplasm × 90 days × Clear all

Sponsor

Interventions

venetoclax 151 Cyclophosphamide 89 Cytarabine 81 Azacitidine 81 fludarabine 77 Specimen Handling 74 Biopsy 57 Rituximab 42 Methotrexate 37 fludarabine phosphate 35 Vincristine 33 Daunorubicin 33 Decitabine 31 obinutuzumab 26 Granulocyte Colony-Stimulating Factor 26 ibrutinib 25 Whole-Body Irradiation 25 Injections 25 blinatumomab 24 Magnetic Resonance Spectroscopy 24 Prednisone 22 Mycophenolic Acid 22 Dexamethasone 22 Busulfan 21 acalabrutinib 20 Stem Cell Transplantation 20 Tacrolimus 19 Filgrastim 19 Doxorubicin 19 pirtobrutinib 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡